Supe S S, Swamy K, Viswanathan N, Kumar M U, Anantha N
Dept of Radiation Physics, Kidwai Memorial Institute of Oncology, Bangalore, India.
Indian J Cancer. 1992 Sep;29(3):148-58.
A retrospective analysis of 291 patients with cancer of the uterine cervix treated with a combination of external and intracavitary radiotherapy was carried out. Patients were either treated with 45 Gy in 20 fractions by five fractions per week or with 42 Gy in 14 fractions by three fractions per week or with 42 Gy in 14 fractions by three fraction per week schedule by external radiotherapy. For brachytherapy the total dose was 24 to 32 Gy at a dose rate of 1.4 to 2.2 Gy per hour. Complication were correlated with total CRE values for point A (CRE TA) and for rectum CRE TR. Correlations of CRE TA with overall complication rate (p value < 0.05) and rectal complication rate (p value < 0.01) were excellent. Lack of correlation was observed between CRETR and overall complication rate (p value > 0.1) as well as rectal complication rate (p value > 0.1). In order to limit Grade II and III rectal and bladder complications to acceptable level, in combined external and intracavitary treatments, CRETA value of less than 2500 reu is suggested.
对291例接受外照射与腔内放疗联合治疗的子宫颈癌患者进行了回顾性分析。患者接受的外照射方案为:每周5次,每次1次,共20次,剂量45 Gy;或每周3次,每次1次,共14次,剂量42 Gy;或每周3次,每次1次,共14次,剂量42 Gy。近距离放疗的总剂量为24至32 Gy,剂量率为每小时1.4至2.2 Gy。并发症与A点的总CRE值(CRE TA)和直肠的CRE值(CRE TR)相关。CRE TA与总体并发症发生率(p值<0.05)和直肠并发症发生率(p值<0.01)的相关性极佳。未观察到CRETR与总体并发症发生率(p值>0.1)以及直肠并发症发生率(p值>0.1)之间存在相关性。为了将II级和III级直肠及膀胱并发症限制在可接受水平,在外照射与腔内放疗联合治疗中,建议CRETA值小于2500 reu。